Literature DB >> 28473424

Glucocorticoids in rheumatoid arthritis: the picture is shaping up.

Frank Buttgereit1, Johannes W Bijlsma2.   

Abstract

Entities:  

Keywords:  Corticosteroids; Early Rheumatoid Arthritis; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2017        PMID： 28473424     DOI： 10.1136/annrheumdis-2017-211187

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

Review 1.  Morning Stiffness in Elderly Patients with Rheumatoid Arthritis: What is Known About the Effect of Biological and Targeted Agents?

Authors:  Chi Chiu Mok
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

Review 2.  Views on glucocorticoid therapy in rheumatology: the age of convergence.

Authors:  Frank Buttgereit
Journal:  Nat Rev Rheumatol       Date:  2020-02-19       Impact factor: 20.543

3.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

Review 4.  [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].

Authors:  D Freier; C Strehl; F Buttgereit
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 5.  [The DRFZ-a pioneer in research on the interaction between immune and stromal cells during de- and regeneration of the musculoskeletal system].

Authors:  Max Löhning; Ping Shen; Maria Dzamukova; Nayar Durán-Hernández; Jay Roodselaar; Anja E Hauser; Alexander Fiedler; Raluca A Niesner; Timo Gaber; Frank Buttgereit
Journal:  Z Rheumatol       Date:  2022-04-12       Impact factor: 1.530

6.  Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis.

Authors:  Yannick Degboé; Michael Schiff; Michael Weinblatt; Roy Fleischmann; Harris A Ahmad; Arnaud Constantin
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

Review 7.  [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].

Authors:  Gernot Keyßer
Journal:  Z Rheumatol       Date:  2021-03-11       Impact factor: 1.372

8.  Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.

Authors:  Edgar Wiebe; Dörte Huscher; Désireé Schaumburg; Andriko Palmowski; Sandra Hermann; Thomas Buttgereit; Robert Biesen; Gerd-Rüdiger Burmester; Yannick Palmowski; Maarten Boers; John H Stone; Christian Dejaco; Frank Buttgereit
Journal:  Ann Rheum Dis       Date:  2022-06-09       Impact factor: 27.973
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.